Crisis Management

  • Corporate personality for pharma in social media

    by - Nov 12, 2015
    In this article, the fifth in a series of ‘how-to’ guides for the pharmaceutical industry, Paul Grant looks at the way in which sometimes indeterminate ‘tone of voice’ can portray something about the personality of your...
  • Tesaro Discovers the Power of the e-Patient

    by - Sep 12, 2015
    By conventional measures of social media success, Ahava Emuna Lange is not a social media ‘celebrity’. At the time of writing, she has 116 followers on Twitter and has posted just 152 tweets. A little over...
  • Managing a Social Media Crisis

    by - Sep 15, 2011
    Background In 2011, the organizers of e-Patient Connections Conference approached Creation Healthcare’s Founder, Daniel Ghinn, after the company’s analysis into recent social media crises in the healthcare arena. They asked if Daniel would prepare a workshop...
  • Handling a Social Media Crisis: Lessons From The Real World

    by - Aug 31, 2011
    If a potential social media PR disaster happens to your organization, do you know how you would respond? At e-Patient Connections in Philadelphia, Creation Healthcare’s CEO Daniel Ghinn will lead a practical workshop that will equip...
  • How to avoid the pitfalls of digital channels

    by - Aug 18, 2011
    This week the PMCPA, the organization responsible for effectively policing the pharmaceutical industry’s Code of Practice in the UK, ruled that Bayer should be cited for promoting prescription-only medicines  to the public via social media earlier this...
  • Introduction to Digital Governance

    by - Aug 18, 2011
    In the pharmaceutical and medical device industries, control of digital activities – including social media – is paramount to avoid fines and ensure that proper strategies and structures are in place to maximise commercial opportunities. A...
  • Is failure an option?

    by - Jun 17, 2011
    No one wants to be wrong; ever. As much as there are trendy business mantras such as ‘Fail Fast’ which apparently encourage failure (as long as you learn quickly), it somehow just doesn’t translate to the...
  • “Shame on you” crisis leads to KV share price plummet

    by - Mar 30, 2011
    Less than three weeks after a Facebook page was set up by one patient angry with KV Pharmaceuticals’ pricing of its newly approved drug Makena, the US Food and Drug Administration (FDA) has today announced that...
  • “Shame on you”: an emerging pharma social media crisis

    by - Mar 17, 2011
    The launch of a Facebook page by pregnant mothers in the USA angry about KV Pharmaceuticals’ pricing of its newly FDA-approved synthetic progesterone product, Makena, raises once again the urgent need for pharmaceutical companies to plan...
Subscribe free to receive monthly eJournal edition